Home Applications 761077 Application 761077
Type BLA
Sponsor AMGEN INC Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761077 Aimovig erenumab-aooe 351(a) Rx 2026-07-01
Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 AIMOVIG ERENUMAB-AOOE INJECTABLE;INJECTION 70MG/ML No No
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 48 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-840 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-841 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-842 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current 55513-843 AIMOVIG erenumab-aooe Amgen Inc BLA Current